New Combo KOs HCV Without Interferon, Ribavirin (CME/CE)

Courtesy MedPage Today Infectious Disease  Wed, 01/18/2012 - 15:00

(MedPage Today) -- A combination of direct-acting antiviral agents aimed at hepatitis C -- and given without standard therapy -- can lead to sustained virologic response in patients with a difficult-to-treat strain of the virus.


 

More related items

DDW: Telaprevir Improves HCV Clearance in Resistant...
CHICAGO (MedPage Today) -- The investigational protease inhibitor telaprevir, added to standard hepatitis C (HCV) treatment, produced a sustained virologic response in about half of patients...

AASLD: Milk Thistle No Help in Chronic HCV (CME/CE)
SAN FRANCISCO (MedPage Today) -- A botanical agent used in the treatment of liver disorders had no detectable effect on hepatitis C virus disease activity in comparison with placebo in...

AASLD: New PI Effective, Safe in HCV Trial (CME/CE)
SAN FRANCISCO (MedPage Today) -- An investigational hepatitis C drug was safe and effective in a small randomized trial, a researcher said here.

Numi's Bouquet Bamboo Gift Set with Clear Teapot and...

Mania By Giorgio Armani For Men. Eau De Toilette...
Mania Was Created For The Man Seeking A Discreet, Elegant, And Classic Signature Scent. The Classical Freshness Of Mania Is Built Around A Sensual Amber-woody Accord That Brings To Mind Warm...


 

Post new comment

The content of this field is kept private and will not be shown publicly.
health-fitness.marc8.com